Intrapatient tacrolimus variability is associated with medical nonadherence among pediatric kidney transplant recipients
Tacrolimus intrapatient variability may be a useful biomarker to identify nonadherence and high-risk patients, allowing for early interventions to prevent adverse graft outcomes.
Authors
- Chryso Katsoufis (ORCID: https://orcid.org/0000-0002-8872-1165)
- Carolyn Abitbol (ORCID: https://orcid.org/0000-0002-0984-3771)
- Jayanthi Chandar (ORCID: https://orcid.org/0000-0002-2859-4184)
- Marissa J. DeFreitas (ORCID: https://orcid.org/0000-0001-9331-1905)
- Vaka K. Sigurjonsdottir (ORCID: https://orcid.org/0000-0003-2776-4601)
- Wacharee Seeherunvong (ORCID: https://orcid.org/0000-0003-0485-5762)
- Tara B. Gavcovich (ORCID: https://orcid.org/0009-0004-3991-1618)
- Eva Rivas (ORCID: https://orcid.org/0000-0002-5816-998X)
- Adela Mattiazzi (ORCID: https://orcid.org/0000-0002-3388-5648)
- Marília Formentini Scotton Jorge (ORCID: https://orcid.org/0000-0003-1667-5160)
- Wendy Glaberson (ORCID: https://orcid.org/0000-0003-0865-3279)
- Claudia Serrano
- Melisa Oliva
Institutions
- University of Miami (US)
- Jackson Memorial Hospital (US)
- Jackson Health System (US)
- Miami Transplant Institute (US)
Publication Details
- Journal
- Frontiers in Transplantation
- Published
- 2025-03-17
- DOI
- https://doi.org/10.3389/frtra.2025.1572928
- Citations
- 1
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.99